Site Management/Investigator Payments Featured Articles

31. Site Networks Find Strength In Numbers With AMRC 1/29/2025

    Jim Kremidas, executive director of the newly launched Association of Multisite Research Corporations (AMRC), talks about the genesis and future of this association, which launched with 14 multisite clinical research corporations (MCRCs) members.

32. Innovation In Clinical Trial Site Payments 1/16/2025

    Senior Product Manager Iain Wood utilized his global expertise in managing clinical trial budgets, payments, and compliance to answer several questions about the complexities of site payments.

33. Bridging Continents For Clinical Development 1/16/2025

    By leveraging Australia's ecosystem as a launchpad, organizations managing both early-stage and advanced development can enhance trial quality and position themselves for success.

34. Don't Let Poor Lab Operations Ruin Your Clinical Trial 1/15/2025

    Clinical laboratory scientist Nancy Muriithi reveals some of the most troubling issues in clinical research lab operations — and offers ways to address them.

35. What Future Laboratory Manuals Should Look Like 12/20/2024

    In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality.

36. How Laboratory Manuals Fail Sites And Sponsors 12/19/2024

    In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.

37. Lab Manual Gaps: Sabotaging Data One Sample At A Time 12/19/2024

    In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.

38. BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil 12/17/2024

    In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.

39. Should We Be Scared Of PE Firms Investing In Sites? 12/16/2024

    It seems lately there's been a lot of vilification of private equity (PE) firms that are purchasing site networks. I'm sure this sentiment has increased during the past few years, but is it justified? 

40. BeiGene Explains The Landscape Of Oncology Trials In Brazil 12/16/2024

    In part one of this two-part series, BeiGene's Brazil and LATAM clinical operations head Lígia Campos details Brazil's cancer treatment landscape and the benefits of expanding oncology trials there.